GLP-1 Drug Costs Are Dropping—But at What Price to Our Health?
As GLP-1 drug prices plunge, a troubling question looms: are we trading short-term weight loss for long-term harm—and a future of lifelong pharmaceutical dependence? THE TOPLINE A Breakthrough—or a Bigger Problem? The Trump Administration has announced a major deal with Novo Nordisk and Eli Lilly to dramatically expand access to GLP-1 weight-loss drugs by reducing […]








